Why it matters: The MHRA advise that due to the risk of disabling and potentially long-lasting or irreversible side effects, systemic fluoroquinolones must only be used in situations when other antibiotics, that are commonly recommended for the infection, are inappropriate.
Description: Number of prescription items for systemic fluoroquinolones per 1000 patients
Explore:
Tagged as: Antimicrobial Stewardship, Standard, Infections, Safety (or browse all measures)
Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.
View measure for NHS England combined →